Abstract:Background: Mitral regurgitation (MR) is one of the common complications of heart failure (HF). The prevalence and characteristics of MR are rarely investigated, especially in the Chinese population. Objectives: The purpose of this study was to determine the prevalence and characteristics of non-organic MR in HF patients and subgroups defined by ejection fraction. Methods: A single-center, hospitalbased, and retrospective chart review study included patients with heart failure admitted to the cardiovascular department from January 2017 to April 2020. Demographic characteristics, laboratory results, and echocardiogram results before discharge were analyzed in different groups defined by left ventricular ejection fraction (EF) using logistic regression and adjusted for confounders. Results: Finally, 2418 validated HF patients (age 67.2 +/- 13.5 years; 68.03% men) were included. The prevalence of MR was 32.7% in HF, 16.7% in HF with preserve EF patients, 28.4% in HF with mid-range EF patients and 49.7% in HF with reduced EF (HFrEF) patients. In the HF with preserved EF group, multivariable logistic regression showed that 4 factors associated with MR including EF (odds ratio (OR) 0.954 (0.928-0.981), p = 0.001), left ventricular posterior wall thickness in diastolic phase (LVPWd) (OR 0.274 (0.081-0.932), p = 0.038), left atrium (LA) dimension (OR 2.049 (1.631-2.576), p < 0.001) and age (OR 1.024 (1.007-1.041), p = 0.007). In the HF with midrange EF group, multivariable logistic regression showed that 3 factors associated with MR including LA dimension (OR 2.009 (1.427-2.829), p < 0.001), triglycerides (TG) (OR 0.552 (0.359-0.849), p = 0.007) and digoxin (OR 2.836 (1.624-4.951), p < 0.001). In the HFrEF group, multivariable logistic regression showed that 7 factors associated with MR including EF (OR 0.969 (0.949-0.990), p = 0.004), (OR 0.161 (0.067-0.387), p < 0.001), LA dimension (OR 2.289 (1.821-2.878), p < 0.001), age (OR 1.016 (1.004-1.027)), p = 0.009), TG (OR 0.746 (0.595-0.936), p = 0.011), diuretics (OR 0.559 (0.334-0.934), p = 0.026) and ICD (OR 1.898 (1.074-3.354), p = 0.027). Conclusions: HF patients had a high burden of MR, particularly in the HFrEF group. Worsen cardiac structure (LA dimension and LVPWd) and function (EF), age, and medical treatment strategy played essential roles in MR.

Assessment of Mitral Regurgitation by Doppler Eehocardlographic Measurement of the Effective Regur gitant Orifice Area

Methodological Study of Flow Field Uniformity of Mitral Valve Using Vector Flow Mapping

Utility of Real-Time Three-Dimensional Transesophageal Echocardiography in the Intraoperative Assessment of Mltral Valve Repair

The Prevalence and Characteristics of Mitral Regurgitation in Heart Failure: A Chart Review Study

Comparison Of The Correlation Of Rebreathing Method And Echocardiography In Heart Failure Patients With Moderate To Severe Mitral Regurgitation

Novel 3-dimensional effective regurgitation orifice area quantification serves as a reliable tool to identify severe mitral valve regurgitation

Preliminary Study about Practical Value of Quantification of Mitral Stenosis by Using Proximal Flow Convergence Method

4D Flow Cardiac MR in Primary Mitral Regurgitation

Improving the poor prognosis of oral squamous cell carcinoma

Quantification of Left‐side Intracardiac Pressures and Gradients Using Mitral and Aortic Regurgitant Velocities by Simultaneous Left and Right Catheterization and Continuous‐wave Doppler Echocardiography

Molecular basis for cell-specific regulation of the NADPH-cytochrome P450 oxidoreductase gene.

Investigating the shortcomings of the Flow Convergence Method for quantification of Mitral Regurgitation in a pulsatile in-vitro environment and with Computational Fluid Dynamics

Real-time Three-Dimensional Echocardiography in Diagnosis and Quantitative Assessment of Congenital Mitral Regurgitation

Updated evaluation of mitral valvular anatomy and regurgitation by echocardiography

Regional geometric differences between regurgitant and non-regurgitant mitral valves in patients with coronary artery disease

Evaluation of a Novel Echocardiographic Three-Dimensional Automated Software for the Assessment of the Aortic Root in Candidates for Transcatheter Aortic Valve Replacement

Evaluation and prediction by using tissue Doppler imaging on patients with left ventricular dilation and dysfunction secondary to organic mitral regurgitation

The mitral to aortic/pulmonary velocity-time integral ratio is a simple, feasible and accurate discriminator for echocardiographic evaluation of severe isolated mitral regurgitation

Assessment of mitral valve regurgitation by cardiovascular magnetic resonance imaging

A Study on Ejection Fraction in Patients with Mitral and Aortic Regurgitation Based on Cardiovascular Models

Mitral Regurgitation Quantification from Multi-channel Ultrasound Images via Deep Learning